Skip to main content
INVITES BIOCORE CO., LTD logo

INVITES BIOCORE CO., LTD — Investor Relations & Filings

Ticker · 216400 ISIN · KR7216400002 KO Professional, scientific and technical activities
Open in API
Filings indexed 169 across all filing types
Latest filing 2022-02-04 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 216400

About INVITES BIOCORE CO., LTD

https://www.bio-core.com/eng/main/main.…

INVITES BIOCORE CO., LTD. is a Contract Research Organization (CRO) that provides comprehensive services to support new drug development. Established in 2001, the company partners with pharmaceutical firms, research institutes, and medical institutions. Its primary services include bioanalytical testing, central lab services, and clinical trial support. The company also specializes in genomic analysis, offering genetic and cell screening, individual genome analysis, and related services to facilitate the advancement of precision medicine and personalized healthcare.

Recent filings

Filing Released Lang Actions
전환가액의조정(제1회차)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory announcement regarding the adjustment of the conversion price for convertible bonds (제1회차 전환가액의 조정). It details the change in conversion price, the number of convertible shares, and the underlying methodology based on market price fluctuations. This type of filing relates to changes in capital structure and financing instruments, which falls under the 'Capital/Financing Update' category.
2022-02-04 Korean
전환가액의조정(제1회차)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory announcement regarding the adjustment of the conversion price for convertible bonds (제1회차 전환가액의 조정). It details the change in conversion price, the number of convertible shares, and the methodology used for the adjustment based on market price fluctuations. This type of filing relates to capital structure changes and financing instruments, which falls under the 'Capital/Financing Update' category.
2021-12-27 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 90% confidence The document is a short regulatory announcement regarding the setting of a record date for the purpose of holding an upcoming Annual General Meeting (AGM). It does not contain the full meeting materials or the report itself, but rather serves as a formal notice of the shareholder record date. Given the nature of the announcement regarding meeting preparation and the lack of a specific category for 'Record Date' notices, it falls under the general regulatory filing category.
2021-12-16 Korean
기업설명회(IR)개최결과
Regulatory Filings Classification · 100% confidence The document is a short, structured announcement detailing the results of an Investor Relations (IR) event held by 'Invites BioCore'. It lists the date, location, attendees, and agenda of the meeting. Since it is a brief notification summarizing the occurrence of an event rather than the full presentation deck or a comprehensive financial report, it falls under the category of a regulatory announcement regarding corporate activities.
2021-11-24 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling and logistics of an Investor Relations (IR) event (기업설명회). It provides the date, time, location (online), target audience, and purpose of the meeting. Since this is an announcement of an upcoming presentation rather than the presentation slides themselves, and it serves as a regulatory notification of an event, it falls under the category of a regulatory filing or announcement regarding corporate activities.
2021-11-15 Korean
전환가액의조정(제1회차)
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from a Korean company (Invites BioCore) detailing the adjustment of the conversion price for convertible bonds (제1회차). This type of disclosure, which involves changes to the capital structure and conversion terms of debt instruments, is classified under 'Capital/Financing Update' (CAP) as it directly relates to the company's financing activities and capital structure adjustments.
2021-10-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.